openPR Logo
Press release

IAH Wellness in Andorra develops a new treatment protocol for Lyme and co-infections

04-01-2025 06:20 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: Notorial
IAH Wellness in Andorra develops a new treatment protocol

Image: https://www.globalnewslines.com/uploads/2025/04/1743497926.jpg

LACI Registered , pronunced "Lay-see" [https://iahwellness.com/laci/], is the new synergistic treatment protocol developed by IAH Wellness for Lyme and co-infections. It is a personalized protocol in four phases which sets the cornerstones of the treatment: IPT, IV Immunotherapy, 4th Generation Human Probiotics and Herbal Treatment. By using this four phase synergistic approach, we manage to target and treat the necessary pathogens in parallell and by doing so achieve a higher success rate, says CEO and Co-Founder Martin Nielsen.

Through combining innovative pharmacological treatments and technologies alongside immune- boosting therapies and naturopathic medicine, we strive to provide Lyme treatment options which are not easily accessible in many other parts of the world, contiues to explain Martin Nielsen.

The pharmacological part of the LACI Registered protocol is centered around utilizing IPT (Insulin Potentiation Therapy) to enhance the efficiency of the delivery of specific IV antibiotics used to target the Lyme and coinfections. This process is also supported by synergistic therapies, to combat the detrimental effects of the infection and to provide a lasting solution. In allignment with the LACI Registered protocol, we use a wide range of oral supplements and stationary treatments. The LACI Registered protocol is divided into a pre-treatment phase at home before going to the clinic, the on-site clinical treatment and a post-treatment phase again at home. The pre-treatment phase permits us to prepare the patient by gently moderating inflammation, gut toxity and decrease the immunesystem overload making the body more responsive to the on-site clinical treatment. The post-treatment is a guided oral supplement phase where we combine antimicrobial herbs with our pro-biotic protocol and supplements. During this phase, we are constantly monitoring the patients and evaluating the process until the goal is achieved and the patient feel that he or she is recovering their previous life and habits.

Lyme Disease is known as the "great imitator" as Lyme disease symptoms have a widespread list of symptoms that mimic many other diseases causing it to be misdiagnosed for fibromyalgia, multiple sclerosis, chronic fatigue syndrome, and various psychiatric illnesses such as depression. Lyme disease can be difficult to diagnose. Sadly, recent data shows more than 85% of Lyme disease patients were not diagnosed until after four months of illness, and over 70% saw four or more doctors before receiving a correct diagnosis.

The CDC estimates cases in the United States now at more than 600,000 people infected annually while acknowledging that Lyme disease can be difficult to diagnose. For this reason, nearly all of the Lyme Disease patients at IAH Wellness have been infected for several years. Because these patients went undiagnosed for so long, they have become "Chronic Lyme Disease" patients, and a majority are suffering from brain infections and therefore have Neurological Lyme Symptoms. The LACI Registered protocol is now giving hope back to this cluster of sufferers adding a light in this otherwise so dark tunnel.
Media Contact
Company Name: IAH Wellness
Contact Person: Press Office
Email: Send Email [http://www.universalpressrelease.com/?pr=iah-wellness-in-andorra-develops-a-new-treatment-protocol-for-lyme-and-coinfections]
Country: United States
Website: https://iahwellness.com/laci/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release IAH Wellness in Andorra develops a new treatment protocol for Lyme and co-infections here

News-ID: 3949987 • Views:

More Releases from Getnews

The U.S. Green Card: Turning a Temporary Stay into a Permanent American Future
The U.S. Green Card: Turning a Temporary Stay into a Permanent American Future
Image: https://www.globalnewslines.com/uploads/2025/12/1766183100.jpg For many people, a U.S. visa is only the beginning. What they truly want is certainty - the ability to live, work, and plan their future in the United States without expiry dates, renewals, or ongoing fear that a single decision could unravel years of effort. That certainty is called a Green Card. Yet despite its importance, the Green Card [https://larhdellaw.com/] process is often misunderstood. Some believe it is only for
The L-1 Visa: How Global Businesses Expand to the U.S. Without Starting From Scratch
The L-1 Visa: How Global Businesses Expand to the U.S. Without Starting From Scr …
Image: https://www.globalnewslines.com/uploads/2025/12/1766182907.jpg For international companies with ambitions to enter the United States, few visa options are as powerful - or as misunderstood - as the L-1 Intracompany Transfer Visa. When used correctly, the L-1 visa allows established businesses to expand into the U.S. market, transfer trusted senior staff, and build a long-term American presence without relying on lotteries, third-party sponsors, or speculative investment routes. When used incorrectly, it becomes one of the
The B-1/B-2 Visitor Visa: Why Careful Preparation Matters More Than Ever
The B-1/B-2 Visitor Visa: Why Careful Preparation Matters More Than Ever
Image: https://www.globalnewslines.com/uploads/2025/12/1766182346.jpg The B-1/B-2 visitor visa [https://larhdellaw.com/]is often described as the most common U.S. visa. That description, while true, can be misleading. Its familiarity causes many applicants to underestimate how closely these visas are scrutinised - and how easily an application can be refused. In today's immigration environment, visitor visas are assessed with a level of caution that surprises even experienced international travellers. The rules themselves have not dramatically changed, but how
The E-2 Visa Explained: How to Invest in the U.S. Without Buying a Green Card (and Why Many Applications Fail)
The E-2 Visa Explained: How to Invest in the U.S. Without Buying a Green Card (a …
Image: https://www.globalnewslines.com/uploads/2025/12/1766182716.jpg For entrepreneurs, investors, and business owners looking to live and work in the United States, the E-2 Treaty Investor Visa remains one of the most attractive - and misunderstood - visa options available. Every year, we speak with applicants who have invested significant money, launched businesses, or even hired staff, only to discover that their E-2 application was refused or delayed due to avoidable legal and strategic errors. The truth

All 5 Releases


More Releases for Lyme

Lyme Disease Diagnostics Market Projected to Show Strong Growth
Advance Market Analytics published a new research publication on "Lyme Disease Diagnostics Market Insights, to 2033" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Lyme Disease Diagnostics market was mainly driven by the increasing R&D spending across the world. Get Free Exclusive PDF Sample
Lyme Disease - Drug Pipeline Landscape, 2022
Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash. Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems. To know more about Lyme Disease - Drug Pipeline ,
Lyme Disease - Drug Pipeline Landscape, 2022 | Global Insight Services
Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash. Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems. Diagnosis of Lyme disease involves lab tests to
Lyme Disease Vaccines - Are They Effective?| Valneva, GlaxoSmithKline Plc.
There is currently no Lyme disease vaccine available. LYMERix®, the only vaccine previously marketed in the United States, was withdrawn from the market in 2002 due to a lack of consumer demand. The vaccine's effectiveness deteriorates over time. Lyme Disease Vaccines Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing
Lyme Disease Therapeutics Market Size Statistics, Facts and Figures
Global Lyme Disease Therapeutics Market: Overview Lyme disease is a contagious disease caused by a bacterium species called Borrelia burgdorferi. It is a tick-borne disease caused by transmission of bacteria to humans through the bite of infected ticks. Common indications of Lyme disease include flu-like symptoms, depression, fatigue, and expanding, circular, reddish skin rashes. View Report : https://www.transparencymarketresearch.com/lyme-disease-therapeutics-market.html If left untreated, these symptoms may worsen and can lead to partial or complete
Lyme Disease Diagnostic Testing Market
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs